NCT06887699

The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

A Randomized Clinical Trial Investigating the Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 212,000 (estimated)
• Sponsor: National Defense Medical Center, Taiwan · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.

Detailed description

The investigators have developed an AI-ECG system that provides real-time notifications for patients with potential occlusion myocardial infarction. This AI algorithm is seamlessly integrated into the Hospital Information System, allowing for the automatic generation of reports whenever an ECG is performed. The purpose of this study is to evaluate the impact of AI-ECG on the timely diagnosis of STEMI, including patients' outcomes and healthcare costs.

Conditions

• OMI - Occlusion Myocardial Infarction
• Artificial Intelligence (AI)
• Electrocardiogram
• Cost-effectiveness Analysis

Interventions

Type	Name	Description
OTHER	AI-ECG P4P program	The AI-ECG system will conduct a real-time analysis of the ECG. When the system identifies potential OMI cases, it will immediately send short message service notifications to the on-duty cardiologists. This will enable the cardiologists to promptly review and confirm the diagnosis.

Timeline

• Start date: 2025-08-01
• Primary completion: 2028-03-31
• Completion: 2028-06-30
• First posted: 2025-03-20
• Last updated: 2026-04-09

Locations

3 sites across 1 country: Taiwan